Medicine and Dentistry
Coronary Artery Disease
100%
Stenosis
34%
Cohort Analysis
31%
Cardiovascular System
30%
Coronary Artery
30%
Coronary Computed Tomography Angiography
28%
Fractional Flow Reserve
28%
Thorax Pain
28%
Hazard Ratio
24%
Cardiovascular Disease
22%
Coronary Angiography
21%
Diagnosis
20%
Positron Emission Tomography
18%
Congestive Heart Failure
17%
Cardiac Magnetic Resonance Imaging
17%
Cardiovascular Risk
16%
Symptom
16%
Coronary Artery Obstruction
15%
Ischemic Heart Disease
15%
Heart Performance
15%
Positron Emission Tomography
15%
Isotopes of Calcium
15%
Tissue Doppler Imaging
14%
Diagnostic Performance
14%
Myocardial Infarction
14%
Angiography
14%
Heart Muscle Ischemia
13%
Computed Tomography Angiography
12%
Heart Muscle Blood Flow
11%
Prevalence
11%
Kidney Graft
11%
Biological Marker
10%
Combination Therapy
10%
Acute Heart Infarction
10%
Bone Density
10%
Heart Sound
10%
Systematic Review
10%
Patient Registry
10%
Heart Failure
9%
Artificial Respiration
8%
Heart Left Ventricle Function
8%
Attributable Risk
8%
Systolic Function
7%
Patient with Hypertension
7%
Troponin I
7%
Computer Assisted Tomography
7%
Ibuprofen
7%
Myocardial Perfusion Imaging
7%
Thermodilution
7%
Cardiac Resynchronization Therapy
6%
Patient Referral
6%
Percutaneous Coronary Intervention
6%
Disease
6%
Essential Hypertension
6%
General Practitioner
6%
Proteomics
5%
Randomized Controlled Trial
5%
Cardiac Computed Tomography
5%
ST Segment Elevation Myocardial Infarction
5%
Athletes
5%
Atherosclerosis
5%
Heart Transplantation
5%
Lipoprotein
5%
Losartan
5%
Cardiomyopathy
5%
Population
5%
Dyspnea
5%
Middle Age
5%
Heart Output
5%
COVID-19
5%
Primary Percutaneous Coronary Intervention
5%
Atrial Fibrillation
5%
Venous Thromboembolism
5%
Anticoagulation
5%
C Reactive Protein
5%
Aortic Stenosis
5%
Electrocardiogram
5%
Dexamethasone
5%
Health Care
5%
Treatment Effect
5%
Arteriosclerosis Obliterans
5%
Coronary Vasospasm
5%
Sinus Node Disease
5%
Drug-Eluting Stent
5%
Bed Rest
5%
Restenosis
5%
Edema
5%
Valsartan
5%
Crackle
5%
Cystatin C
5%
Mineralocorticoid Antagonist
5%
Amputation of Lower Limb
5%
Methapyrilene
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Microangiopathy
5%
Sacubitril
5%
Staphylococcus Pasteuri
5%
Heart Failure with Reduced Ejection Fraction
5%
Liver Disease
5%
Exercise Electrocardiography
5%
Keyphrases
Confidence Interval
21%
Stable Chest Pain
11%
Anticoagulants
10%
Cardiovascular Events
10%
Hazard Ratio
10%
Major Adverse Cardiovascular Events
9%
Coronary Computed Tomography Angiography
9%
High Risk
8%
Chest Pain
6%
Obstructive Coronary Artery Disease
6%
Cardiovascular Mortality
6%
Likelihood Estimation
5%
National Cohort Study
5%
Etiology
5%
Suspected Coronary Artery Disease
5%
Cardiovascular Risk
5%
Intermediate Coronary Lesion
5%
Lipoproteins
5%
Ketogenic Diet
5%
Yield Impact
5%
Ketone Bodies
5%
Cystectomy
5%
Atrial Pacing
5%
Cardiovascular Outcomes
5%
Sinus Node Dysfunction
5%
Cardiovascular Effects
5%
3-hydroxybutyrate
5%
Free Testosterone
5%
Enhanced Scan
5%
C-reactive Protein
5%
Chronic Coronary Syndrome
5%
Baseline Risk
5%
Ureteral Stricture
5%
Dual Pathway Inhibition
5%
Obese Men
5%
Risk Factor Assessment
5%
Specific Risk
5%
Coronary Plaque Characteristics
5%
Net Clinical Benefit
5%
Stricture
5%
Anticoagulation Strategy
5%
Middle-aged
5%
Troponin
5%
Chronic Kidney Disease
5%
Coronary Artery Plaque
5%
Myocardial Perfusion Defect
5%
Phonocardiography
5%
Cardiac Output
5%
Radiological Assessment
5%
Failure Impact
5%
Free Estradiol
5%
Free-free
5%
Obese Women
5%
Low Bone Mineral Density
5%
Thoracic Spine
5%
Bone Mineral Density
5%
Quantitative Computed Tomography
5%
Cancer Treatment
5%
Cancer-associated Thrombosis
5%
Direct Oral Anticoagulants
5%
Mineralocorticoid Receptor Antagonists
5%
Beta-blockers
5%
Chronic Heart Failure
5%
Reduced Left Ventricular Function
5%
Ischemic Heart Disease
5%
Congestion
5%
Edema
5%
Cardiac Filling Pressures
5%
Dyspnea
5%
Heart Failure with Preserved Ejection Fraction (HFpEF)
5%
Functional Pathology
5%
Pulmonary Crackle
5%
Sacubitril-valsartan
5%
Low Cardiac Output Syndrome
5%
Renin-angiotensin-aldosterone System Blockers
5%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
5%
4 pillars
5%
Medical Treatment
5%
Treatment Strategy
5%
Organ Procurement Surgery
5%
Venous Thromboembolism
5%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
5%
Bleeding Risk
5%
Acute Pericarditis
5%
Danish National Patient Registry
5%
Cardiac Arrest
5%
In-hospital Cardiac Arrest
5%
New Onset
5%
Clinical Risk Prediction
5%
Heart Failure Readmission
5%
Bleeding
5%
Nursing and Health Professions
Coronary Artery Disease
53%
Coronary Angiography
19%
Stenosis
16%
Confidence Interval
15%
Thorax Pain
15%
Coronary Artery Calcium Score
11%
Percutaneous Coronary Intervention
10%
Coronary Artery Obstruction
10%
Heart Output
10%
Polyethylene Terephthalate
10%
Heart Muscle Ischemia
10%
Symptom
10%
Acute Heart Infarction
10%
Heart Muscle Blood Flow
10%
Computed Tomographic Angiography
10%
Fractional Flow Reserve
10%
Perfusion
9%
Diagnosis
8%
Angiography
8%
Infusion
7%
Predictive Value
7%
Congestive Heart Failure
7%
Electrocardiogram
6%
Cardiovascular Magnetic Resonance
6%
General Practitioner
6%
Patient Referral
6%
ST Segment Elevation Myocardial Infarction
5%
Hazard Ratio
5%
Lipoprotein A
5%
Diabetes Mellitus
5%
Restenosis
5%
Generator
5%
Vascular Resistance
5%
Posttraumatic Stress Disorder
5%
Takotsubo Cardiomyopathy
5%
Cardiomyopathy
5%
Exercise Electrocardiography
5%
Imaging
5%
Losartan
5%
Coronary Artery Spasm
5%
General Practice
5%
3 Hydroxybutyric Acid
5%
Athletes
5%
Ketone Bodies
5%
Drug Eluting Stent
5%
Population
5%
Heart Sound
5%
Bone Density
5%
Bacterial Endocarditis
5%
Comorbidity
5%
Anticoagulation
5%
Lactic Acid
5%
Therapy Delay
5%
Transluminal Coronary Angioplasty
5%
Angioplasty
5%
Clinical Management
5%
Nuclear Magnetic Resonance
5%
Combination Therapy
5%
Computer Assisted Tomography
5%
Spectroscopy
5%
Systematic Review
5%
Disease Severity
5%
Hospital Readmission
5%